Abstract:Background— We previously demonstrated that macrophage low-density lipoprotein receptor (LDLR)–related protein 1 (LRP1) deficiency increases atherosclerosis despite antiatherogenic changes including decreased uptake of remnants and increased secretion of apolipoprotein E (apoE). Thus, our objective was to determine whether the atheroprotective effects of LRP1 require interaction with apoE, one of its ligands with multiple beneficial effects. Methods and Results— We examined atherosclerosis development in mice with specific deletion of macrophage LRP1 (apoE −/− MΦLRP1 −/− ) and in LDLR −/− mice reconstituted with apoE −/− MΦLRP1 −/− bone marrow. The combined absence of apoE and LRP1 promoted atherogenesis more than did macrophage apoE deletion alone in both apoE-producing LDLR −/− mice (+88%) and apoE −/− mice (+163%). The lesions of both mouse models with apoE −/− LRP1 −/− macrophages had increased macrophage content. In vitro, apoE and LRP1 additively inhibit macrophage apoptosis. Furthermore, there was excessive accumulation of apoptotic cells in lesions of both LDLR −/− mice (+110%) and apoE −/− MΦLRP1 −/− mice (+252%). The apoptotic cell accumulation was partially due to decreased efferocytosis as the ratio of free to cell-associated apoptotic nuclei was 3.5-fold higher in lesions of apoE −/− MΦLRP1 −/− versus apoE −/− mice. Lesion necrosis was also increased (6 fold) in apoE −/− MΦLRP1 −/− versus apoE −/− mice. Compared with apoE −/− mice, the spleens of apoE −/− MΦLRP1 −/− mice contained 1.6- and 2.4-fold more total and Ly6-C high monocytes. Finally, there were 3.6- and 2.4-fold increases in Ly6-C high and CC-chemokine receptor 2–positive cells in lesions of apoE −/− MΦLRP1 −/− versus apoE −/− mice, suggesting that accumulation of apoptotic cells enhances lesion development and macrophage content by promoting the recruitment of inflammatory monocytes. Conclusion— Low-density lipoprotein receptor protein 1 exerts antiatherogenic effects via pathways independent of apoE involving macrophage apoptosis and monocyte recruitment.

Lox-1 Deletion and Macrophage Trafficking in Atherosclerosis

Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E–Deficient Mice

LOX-1 Deletion Decreases Collagen Accumulation in Atherosclerotic Plaque in Low-Density Lipoprotein Receptor Knockout Mice Fed a High-Cholesterol Diet

Abstract 1339: LOX-1 Ablation Reduces Atherosclerosis

Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages

Biology Of Lox-1 In Relation To Atherogenesis

Low-Density Lipoprotein Receptor–Related Protein 1 Prevents Early Atherosclerosis by Limiting Lesional Apoptosis and Inflammatory Ly-6C <sup>high</sup> Monocytosis

Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

Anti-Lox-1 Rescues Endothelial Function in Coronary Arterioles in Atherosclerotic Apo-E Knockout Mice

The Dynamics Of Macrophage Infiltration Into The Arterial Wall During Atherosclerotic Lesion Development In Low-Density Lipoprotein Receptor Knockout Mice

Gene inactivation of lysyl oxidase in smooth muscle cells reduces atherosclerosis burden and plaque calcification in hyperlipidemic mice

Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ.

Lox-1, Mtdna Damage, and Nlrp3 Inflammasome Activation in Macrophages: Implications in Atherogenesis

Low-Density Lipoprotein Receptor-Related Protein 1 Prevents Early Atherosclerosis By Limiting Lesional Apoptosis And Inflammatory Ly-6c(High) Monocytosis Evidence That The Effects Are Not Apolipoprotein E Dependent

Dynamics Of Macrophage Infiltration Into The Arterial Wall At Different Stages Of Atherosclerotic Lesion Development And Dependency On Macrophage Abca1 Expression

Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice

Role of Ox-LDL and LOX-1 in Atherogenesis

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

Macrophage ABCA2 Deletion Modulates Intracellular Cholesterol Deposition, Affects Macrophage Apoptosis, and Decreases Early Atherosclerosis in LDL Receptor Knockout Mice.

Macrophagic CD146 Promotes Foam Cell Formation and Retention During Atherosclerosis